1. Home
  2. CPHI vs MYO Comparison

CPHI vs MYO Comparison

Compare CPHI & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

N/A

Current Price

$0.98

Market Cap

46.5M

Sector

Health Care

ML Signal

N/A

Logo Myomo Inc.

MYO

Myomo Inc.

N/A

Current Price

$1.73

Market Cap

44.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CPHI
MYO
Founded
N/A
2004
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.5M
44.8M
IPO Year
2008
2017

Fundamental Metrics

Financial Performance
Metric
CPHI
MYO
Price
$0.98
$1.73
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
1.0M
646.3K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,144,268.00
$1,000,000,000.00
Revenue This Year
N/A
$9.10
Revenue Next Year
N/A
$13.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40814.79
52 Week Low
$0.38
$0.61
52 Week High
$19.19
$1.89

Technical Indicators

Market Signals
Indicator
CPHI
MYO
Relative Strength Index (RSI) 46.90 65.54
Support Level $0.54 $0.69
Resistance Level $1.43 N/A
Average True Range (ATR) 0.09 0.18
MACD -0.04 0.05
Stochastic Oscillator 5.01 83.82

Price Performance

Historical Comparison
CPHI
MYO

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.

Share on Social Networks: